SCHEMBL4551574

SCHEMBL4551574

COC(=O)c1cc(-c2cc[nH]n2)ccc1OCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 1/20 0.49
LRRK2 Q5S007 3/20 0.44
LMNA P02545 1/20 0.43
HPGD P15428 1/20 0.43
FOLH1 Q04609 1/20 0.43
DHODH Q02127 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
SMPD1 P17405 2/20 0.42
MCL1 Q07820 1/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
POLB P06746 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HTT P42858 1/20 0.42
MAPT P10636 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3605628 0.81 PDE4A (0.49) LMNAHPGDSMPD1KDM4EALDH1A1
SCHEMBL12848500 0.77 RAB9A (0.54) PRMT5LMNAHPGDKDM4EALDH1A1
SCHEMBL11563262 0.76 MAOB (0.56) LRRK2LMNAHPGDFOLH1L3MBTL1
SCHEMBL11565369 0.76 LRRK2 (0.59) LRRK2LMNAHPGDFOLH1L3MBTL1
SCHEMBL4416634 0.76 FOLH1 (0.58) LMNAHPGDFOLH1L3MBTL1SMPD1
SCHEMBL12848927 0.76 HRH3 (0.53) PRMT5LRRK2HPGDDHODHL3MBTL1
SCHEMBL1315978 0.76 PRMT5 (0.48) PRMT5LRRK2LMNAHPGDKDM4E
SCHEMBL853069 0.75 FOLH1 (0.57) LMNAHPGDFOLH1L3MBTL1SMPD1
SCHEMBL6680832 0.75 HPGD (0.51) LMNAHPGDFOLH1L3MBTL1SMPD1
SCHEMBL5431545 0.75 LRRK2 (0.63) LRRK2LMNAHPGDFOLH1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270435-A1 Spiroketone Acetyl-CoA Carboxylase Inhibitors CORBETT JEFFREY WAYNE 2009-10-29 US disclosed
CN-101541809-A Spiroketone acetyl-CoA carboxylase inhibitors PFIZER PROD INC (US) 2009-09-23 CN disclosed
EP-2097420-A1 SPIROKETONE ACETYL-COA CARBOXYLASE INHIBITORS Pfizer Products Inc. (US) 2009-09-09 EP disclosed
WO-2008065508-A1 SPIROKETONE ACETYL-COA CARBOXYLASE INHIBITORS PFIZER PRODUCTS INC. (US) 2008-06-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270435-A1 Spiroketone Acetyl-CoA Carboxylase Inhibitors ACACA, PC, ACACB PRMT5 1571/4885LRRK2 897/4885LMNA 2708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.